Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
about
Racial and Regional Differences in Rates of Invasive Pneumococcal Disease.Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France.Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013Streptococcus pneumoniae serotype 19A: Worldwide epidemiology.Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era.Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries.Necrotizing pneumonia and acute purulent pericarditis caused by Streptococcus pneumoniae serotype 19A in a healthy 4-year-old girl after one catch-up dose of 13-valent pneumococcal conjugate vaccine.The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease.Necrotizing pneumonia and acute purulent pericarditis caused by Streptococcus pneumoniae serotype 19A in a healthy 4-year-old girl after one catch-up dose of 13-valent pneumococcal conjugate vaccine.Invasive disease caused simultaneously by dual serotypes of Streptococcus pneumoniae.Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era.Serotype 35B Pneumococcal Meningitis in an Infant: Effect of Conjugate Vaccines on Invasive Disease and Implications for Practice.Evaluation of newborn sickle cell screening programme in England: 2010-2016.
P2860
Q36210595-21238198-0492-43F9-A5EE-0CC7C31B5359Q36650547-181EA111-36DF-4B9B-9D09-B6F0DCD8BA0EQ36989792-75FC28F9-576D-4FC4-A553-88DAEAC4424EQ38637072-80E6FB42-B568-4142-ACC9-2C03DEE74FDDQ38960271-918B6194-BA8F-40DC-A581-AAEE6829DF78Q40242598-C6F930D8-DEF1-4DD1-8BED-24F72611FEB8Q40714970-E228DB50-B50C-494A-B03A-3589695731E4Q40780392-86EEBF77-4A41-46C2-A499-686C76E16D52Q41263454-B16417DE-E735-4874-9C44-AF9ADC9FA55BQ46236173-8B92CC38-5447-4E6C-8F8C-9D19A96B3255Q48180820-17639DBA-6E24-4F10-8CE6-3AE71DC34BBAQ48183164-26B4FB08-CA48-446B-AF36-1EA3DB00252AQ50148088-E0C6BF9E-889A-431D-9E3C-8F44BDCC5A45
P2860
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@ast
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@en
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@nl
type
label
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@ast
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@en
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@nl
prefLabel
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@ast
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@en
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@nl
P2860
P356
P1433
P1476
Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
@en
P2093
Brandon Coombes
Lawrence C Madoff
P2860
P304
P356
10.1542/PEDS.2014-0473
P407
P577
2014-07-07T00:00:00Z